产品货号：
Z34769
中文名称：
MEK2/MAP2K2抗体
英文名称：
Anti-MEK2/MAP2K2 Antibody (Clone#OTI1A2)
产品规格：
50μl|100μl|150μl
发货周期：
1～3天
产品价格：
询价
| 抗体名称 | Anti-MEK2/MAP2K2 Antibody (Clone#OTI1A2) |
| 指标别名 | ERK activator kinase 2;MAP kinase kinase 2;MAP2K2;MAPK/ERK kinase 2;MAPKK 2;MAPKK2;MEK 1/2;MEK 2;MEK1/2;MEK2;MKK2;PRKMK2 |
| 克隆性 | Monoclonal |
| 检验物种 | human,monkey,mouse,rat,dog |
| 应用范围 | WB,IHC,IF |
| 基因名称 | MAP2K2 |
| 克隆号 | OTI1A2 |
| 抗体来源 | Mouse |
| 抗体类型 | IgG2a |
| 免疫原 | Full length human recombinant protein of human MAP2K2(NP_109587) produced in HEK293T cell. |
| 实际分子量 | 44.2KD |
| 成分 | PBS (PH 7.3) containing 1% BSA,50% glycerol and 0.02% sodium azide. |
| 纯化方式 | Purified from mouse ascites fluids or tissue culture supernatant by affinity chromatography (protein A/G) |
| 浓度 | 500μg/mL |
| 产品形态 | 溶液 |
| 保存条件 | Stable for 12 months from date of receipt.Store at -20℃ as received. |
| 背景资料 | The protein encoded by this gene is a dual specificity protein kinase that belongs to the MAP kinase kinase family.This kinase is known to play a critical role in mitogen growth factor signal transduction.It phosphorylates and thus activates MAPK1/ERK2 and MAPK2/ERK3.The activation of this kinase itself is dependent on the Ser/Thr phosphorylation by MAP kinase kinase kinases.Mutations in this gene cause cardiofaciocutaneous syndrome (CFC syndrome),a disease characterized by heart defects,mental retardation,and distinctive facial features similar to those found in Noonan syndrome.The inhibition or degradation of this kinase is also found to be involved in the pathogenesis of Yersinia and anthrax.A pseudogene,which is located on chromosome 7,has been identified for this gene.[provided by RefSeq,Jul 2008] |
| Uniprot ID | P36507 |
| 基因名全称 | mitogen-activated protein kinase kinase 2 |
| 蛋白名全称 | Dual specificity mitogen-activated protein kinase kinase 2 |
| 推荐稀释比 | Western blot (WB) 1:200～4000 Immunohistochemistry in paraffin section (IHC) 1:150 Immunofluorescence (IF) 1:100 |
相关搜索：MEK2/MAP2K2抗体，MEK2抗体，MAP2K2单抗，Anti-MEK2/MAP2K2 Antibody (Clone#OTI1A2)